Literature DB >> 26427638

REM sleep Behaviour Disorder.

Luigi Ferini-Strambi1, Fabrizio Rinaldi2, Enrico Giora3, Sara Marelli3, Andrea Galbiati3.   

Abstract

Rapid Eye Movement (REM) sleep Behaviour Disorder (RBD) is a REM sleep parasomnia characterized by loss of the muscle atonia that typically occurs during REM sleep, therefore allowing patients to act out their dreams. RBD manifests itself clinically as a violent behaviour occurring during the night, and is detected at the polysomnography by phasic and/or tonic muscle activity on the electromyography channel. In absence of neurological signs or central nervous system lesions, RBD is defined as idiopathic. Nevertheless, in a large number of cases the development of neurodegenerative diseases in RBD patients has been described, with the duration of the follow-up representing a fundamental aspect. A growing number of clinical, neurophysiologic and neuropsychological studies aimed to detect early markers of neurodegenerative dysfunction in RBD patients. Anyway, the evidence of impaired cortical activity, subtle neurocognitive dysfunction, olfactory and autonomic impairment and neuroimaging brain changes in RBD patients is challenging the concept of an idiopathic form of RBD, supporting the idea of RBD as an early manifestation of a more complex neurodegenerative process.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neurodegenerative disorders; Neurophysiology; RBD; Sleep; Treatment

Mesh:

Year:  2015        PMID: 26427638     DOI: 10.1016/j.parkreldis.2015.09.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Alterations of the brain network in idiopathic rapid eye movement sleep behavior disorder: structural connectivity analysis.

Authors:  Kang Min Park; Ho-Joon Lee; Byung In Lee; Sung Eun Kim
Journal:  Sleep Breath       Date:  2018-10-12       Impact factor: 2.816

Review 2.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

3.  Contrast sensitivity visual acuity in REM sleep behavior disorder: a comparison with and without Parkinson disease.

Authors:  Whitney H Whitfield; Garrett Q Barr; Matthew J Khayata; Peggy H Vogt; Eric M Keasler; Jacqueline M Sanchez; Ziyan Song; Marvin Dieujuste; Brandon Cardon; Ryan Riggs; Karina N Pique; Elliot Merin; David Y Huang; Charles G Maitland
Journal:  J Clin Sleep Med       Date:  2020-01-14       Impact factor: 4.062

Review 4.  Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.

Authors:  Ane Murueta-Goyena; Ane Andikoetxea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

Review 5.  Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.

Authors:  Bruce A Chase; Katerina Markopoulou
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.